Direxion Daily S&P Biotech Bull 3X Shares

LABU
$303.45 (+ $21.28 + 7.54%)
Last updated: 2026-07-03 22:10 UTC
LABU Metrics
Exchange
🇺🇸 NYSE ARCX
NYSE ArcaUnited StatesAmerica/New_York
SectorTrading--Leveraged Equity
IndustryDirexion Funds
ISINUS25460G1206
CUSIP25460G120
Market Price303.45
Dividend Yield N/A
Dividend Growth
1Y +495.94%
3Y +154.54%
5YN/A
10YN/A
Annual Dividend 3.48
Latest Payout ($)0.91
Latest Payout Date2025-12-31
Dividend Frequency N/A
P/E RatioN/A
EPSN/A
Market CapN/A
Book ValueN/A
Price to BookN/A
Beta0.09
52w High179.14
52w Low32.55
Next Earnings DateN/A

Direxion Daily S&P Biotech Bull 3X Shares trades under ticker LABU on NYSE as an ETF. Use this page to review its stock price, dividends, and price history. The page also shows Trading--Leveraged Equity exposure. Identifiers: ISIN US25460G1206, CUSIP 25460G120.

About the Company
Direxion Daily S&P Biotech Bull 3X Shares is an exchange-traded fund (ETF) designed to provide investors with 300% of the daily performance of the S&P Biotechnology Select Industry Index, before fees and expenses. This leveraged ETF primarily aims to amplify the returns of short-term investments by focusing on biotechnology stocks that are part of the S&P index. These underlying companies are engaged in the research, development, manufacturing, and marketing of healthcare products, particularly those with a strong focus on genetics, biopharmaceuticals, and diagnostic advancements. Due to its leveraged nature, this fund plays a significant role for traders who seek to capitalize on short-term market movements in the biotech sector. It is mainly utilized by investors with a high-risk tolerance looking to maximize exposure in a sector known for its innovation and potential for rapid growth. While it provides powerful market exposure, it's important to note its volatile nature, which makes it more suitable for active traders monitoring market conditions closely rather than long-term buy-and-hold strategies.
Price History